Purpose: Streptococcus pneumoniae is a pathogen that cause significant mortality and morbidity in humans. In particular, bacteremia, pneumonia, meningitis and middle ear inflammation. S.pneumoniae can cause many diseases in children and adults. Recently, S.pneumoniae is the most important cause of acute respiratory tract diseases in developing countries. Increasing antibiotic resistance in S.pneumoniae strains has recently gained importance. The aim of our study was to investigate the antimicrobial susceptibility and distribution of pneumococcal serotypes of S.pneumoniae strains isolated in our University Hospital.
S.pneumoniae is one of the most important cause of morbidity and mortality among children under 2 years of age, and elderly patients especially in developing countries. Community-acquired pneumonia can be fatal especially in adults over 60 years of age. S.pneumoniae is a member of upper respiratory tract microbiome. It causes many diseases such as meningitis, otitis media, sinusitis and bacteremia, as well as pneumonia (1) .
S.pneumoniae have been serotyped according to their capsule polysaccharides and more than 90 distinct pneumococcal serotypes have been identified. Serotype distribution and antibiotic resistance varies by age, geographic regions and socio-economic status. The most common 23 serotypes that cause infections have been found in polysaccharide pneumococcal vaccine. However, this vaccine is not effective for children under 2 years of age. Conjugated vaccines covering 7 serotypes have been developed for children under 2 years of age and being used since 2005. The first choice of therapy in S.pneumoniae infections is penicillin but an obvious penicillin resistance was observed in recent years, especially resistance to erythromycin is crucial in macrolides, and similar increase has been observed as in erythromycin resistance too. Moreover, resistance to trimethoprim/sulfamethoxazole is INTRODUCTION also in high levels. Some S.pneumoniae strains of some serotypes have shown higher antibiotic resistance and 80% of penicillin resistant strains consist of the serotypes that are included in conjugated vaccine (1, 2) .
In our study, we aimed to determine antibiotic resistance and serogroups/serotypes of S.pneumoniae strains isolated in our hospital, to determine compatibility levels of them with vaccine serotypes and to compare these results with previous studies.
METHODS

Bacterial strains
In this study, 80 S.pneumoniae strains were isolated from various samples of children and adult patients referred to the Department of Microbiology between 2012-2013.
The isolates were obtained from sputum (56 strains), blood cultures (nine strains), nasal secretions (four strains), throat swabs (four strains), tracheal aspirates (two strains), bronchoalveolar lavages (six strains), biopsy (one strain) and conjunctival smear (one strain). Seventy-six strains were isolated from adults and four from children. Twenty-eight strains were isolated from inpatients and 52 from outpatients.
S.pneumoniae strains were stored in 10% glycerol at-70°C. After thawing the stored strains were cultured by direct-plating to 5 % sheep blood agar. S. pneumoniae was identified according to its Gram stain smears morphology, catalase negative reaction, bile solubility and its susceptibility to optochin. Serogroups/serotypes of S.pneumoniae strains were determined by latex agglutination method (7-10-13-valent Pneumotest-Latex kit, Statens Serum Institude, Denmark) by using ready-to-use solutions containing latex particles coated by antiserums against polysaccharides of S.pneumoniae capsule acquired from rabbit and these serogroup/ serotypes were examined. Moreover, sensitivity tests of strains against various antibiotics were performed by disc diffusion and E-test methods.
Antimicrobial Agents
Antibiotics used in this study were penicillin erythromycin, clindamycine, vancomycine, tetracycline, ofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, chloramphenicol, rifampicin and linezolid.
Susceptibility Testing
Penicillin minimum inhibitory concentration (MIC) values were measured using E-test method (bioMerieux, France) on MuellerHinton agar containing 5% sheep blood; oxacillin, erythromycin, clindamycine, vancomycine, tetracycline, ofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, chloramphenicol, rifampicin and linezolid susceptibilities were measured using disk diffusion technique on the same agar according to CLSI guidelines. The control strain was S.pneumoniae ATCC 49619.
RESULTS
Our study involved 80 S.pneumoniae strains isolated from various clinical cases accepted tothe laboratory of Medical Microbiology between September 2012-September 2013.56 of S.pneumoniae strains were sputum samples (70%), four (5%) were nasal swab samples, one (1.25%) was throat swab sample, one (1.25%) was eye swab sample, nine (11.25%) were blood samples, six (7.5%) were bronchoalveolar lavage (BAL) samples, two (2.5%) were endotracheal aspirate (ETA) samples and one (1.25%) was biopsy sample.
In our study, of 11 serogroup/serotypes serogroup 19 (17 strains), serogroup 6 (7 strains), serogroup 23 (6 strains), serotype 14 (6 strains), serogroup 18 (5 strains), serotype 3 (4 strains), serogroup 7 (3 strains), serogroup 9 (3 strains), serotype 5 (2 strains), serotype 1 (1 strains), serotype 4 (1 strain) were found, respectively. Of the 80 strains 55 (68.75%) were serogrouped/serotyped, whereas 25 (31.25%) could not ( Table 1) . Three of four strains isolated from juvenile patients were serotyped; two of them were sputum samples and other was throat swab sample; their serogroups were determined as serogroup 6, serogroup 23 and serogroup 19, respectively. S.pneumoniae strains which could not be serotyped/serogrouped were mostly sputum samples (four strains), BAL samples (two strains), ETA sample (one strain) and conjunctival smear samples (3), respectively. Only one strain isolated from sputum sample which is one of four juvenile patients could not be typed. In sputum samples, the most common serogroups were 19, 6 and 18. Three sputum samples of juvenile patients were found serogroup 19, 23 and 6 respectively. Four of five blood samples were found serogroup 19. While forty-four of eighty strains were found to be resistant to oxacillin, thirteen of these strains were found to be serogroup 19. According to E-test findings, 39 (48.75%) strains were resistant to oral penicillin at low level and 5 (6.25%) strains were resistant to penicillin at high level.
Due to results of penicillin E-test, distribution of serotype/ serogroups, 13 strains having low-level resistance were determined to be in serogroup 19. Three strains of five high-level resistant strains were found as serogroup 23 ( Table 2 ).
The highest resistance was observed in trimethoprim/ sulfamethoxazole as 45%; this was followed with 31.25% in erythromycin. According to various studies of penicillin resistance in various countries of the world; one study in USA detected that 32% of 1647 strains showed penicillin resistance (4). In an Asian study, penicillin resistance rates and CLSI parenteral penicillin resistance rates of 2184 strains were calculated as 0.7% and 57.5%, respectively (5).
In a review about resistance profiles, penicillin resistance rates in Spain, France, Greece and Israel were determined between 25-50% ; in Portugal, Ireland, Finland and Turkey were between 10-25% ; in Italy 5-10%; in England, Germany, Austria, Norway and Sweden it was in between 1-5% (2). 
Can not be serotyped, (n): Intermediate resistance, SXT: Sulfamethoxazole-Trimethoprim According to studies about penicillin resistance, one study performed in Istanbul between 2008-2010 has shown that 61 pneumococcus strains have had 54% low-level resistance to penicillin and 8.2% high-level resistance (6) . In a study performed in our hospital in 2008, 97 S.pneumoniae strains were detected to have low-level resistance as 28% to penicillin and high level resistance as 3.1% (7).
In our study, 44 S.pneumoniae strains (55%) were found to be resistant to oxacilin. According to oral penicillin MIC values, 39 pneumococcus strains (48.75) showed low-level resistance to penicillin. Five pneumococcus strains (6.25%) were shown to have high-level resistance to penicillin. According to parental penicillin criteria, there were no resistance. Low-level resistance to penicillin was found higher than the other studies have shown. These findings emphasize a current increase in penicillin resistance.
The highest resistance, was observed for trimethoprim/ sulfamethoxazole. In a study from Taiwan, 837 strains were resistant to trimethoprim/sulfamethoxazole in a rate of 81% (8) . Between 1988 Between -1992 strains in Brazil were shown to be resistant to trimethoprim/sulfamethoxazole in a rate of 29.2% (9) .
A study in Turkey has indicated that trimethoprim/ sulfamethoxazole and erythromycin resistance rates of 61 pneumococcus strains isolated between 2008-2010 were 67.2% and 55.8%, respectively (5) . Our study also demonstrated that the resistance rate against trimethoprim/sulfamethoxazole was 45% while the intermediate resistance rate was 6.2%. In our study, serogroup 19 was determined to have the highest resistance rate against trimethoprim/sulfamethoxazole and erythromycin. Tetracycline resistance was also high (28.75%).
In various studies, serogroups 19, 6, 1, 18 have been reported to have multiple antibiotic resistance (10). In our study, the highest antibiotic resistance was detected in serogroup 19, serogroup 6, serogroup 18 and serogroup 23, respectively. Resistance levels of serogroup 7, serogroup 9, serotype 4 and serotype 3 were low and untyped 25 strains were observed to have highlevel resistance. 21 strains were detected to have multiple drug resistance and these strains were serogroups 19, 6, 23, 18, 14 and 3. Three strains of multiple drug resistant strains belong to unserotyped group. There was no resistance for linezolid, vancomycin and rifampicin.
Nowadays, vaccine applications as well as antibiotic usage have been reported to be effective on prevalence of pneumococcus serotypes having antibiotic resistance. Beginning with the vaccine application, it was reported that many countries have decreasing numbers of resistant pneumococcus serotypes while antibiotic usage decreased in pneumococcus infections. Many countries applied pneumococcus vaccines to their vaccination programs and by providing protection by vaccines, some serotypes decreased. Decreased serotypes were generally reported to be resistant serotypes (1).
In the studies reported from many countries in the world, after vaccination serotype 19A was reported as both to be the common and to be the serotype which has the highest possibility of resistance (11) .
It was considered to be the result of vaccination programs that the prevalence of serotypes which could not be avoided by vaccination is expected to be increased in time. Variation in serotype distribution has occurred in time and geographically. New clones derived through clonal propagation and capsular changes are crucial for antibiotic resistance.
According to the results of our study, the number of nonserotyped strains was calculated as 25 (31.25%). Of serotyped strains, 17 strains (21.25%) which showed the highest resistance rate were determined as serogroup 19 as similar in other studies (3, 5, 8, 9) . Other serotypes which are frequently compared except serogroup 19 were found as seven strains in serogroup 6 (8.75%); 6 strains in serotype 14 (7.50%); six strains in serogroup 23 (7.50%) and five strains in serogroup 18 (6.25%).
Although, the pneumococcal vaccine decreases nasopharyngeal carriage and obtain herd immunity in sensitive populations, to our knowledge there is not enough data about pneumococus serotypes, serogroups and antimicrobial susceptibility in Turkey. Soysal et al. (2016) reported that, 45% of S.pneumoniae strains isolated were non-vaccine type and 55% were vaccine type (PCV7 and PCV 13). They also reported that frequently isolated serotypes were 6A/B/C (n = 22, 16.5%), 19F (n = 18, 13.5%), 23F (n = 15, 11.2%), serotype 9V/A (n = 10, 7.5%), 12F (n = 5, 4.5%), 15A/F (n = 7, 4.5%) and 22 A/F (n = 6, 4.5%). According to the results, which based on the minimum inhibitory concentration (MIC) values, S. pneumoniae strains found penicillin resistant with rate of 62%, and 13% of the strains were ceftriaxone resistant. Erythromycin and clindamycin resistance were 43% and 31%, respectively (12) . Correlatively with these results, a study by Arvas et al (2017) also determined that, vaccine type serotypes were detected in 12.6% of children who received full-dose PCV13 vaccine and those strains were found penicillin susceptible with the rates of 85.7% (13) . In our study, similar to other studies from Turkey, serogroup 19 and 6 were detected frequently. S. pneumoniae isolates resistance rates were 31.25% for erythromycin and for clindamycin% 21.25. Serogroups 19, 6, 23 and 18 were found more resistant than the other serogroups. The highest resistance rates to almost all antibiotics were found in serogroup 19.
These findings demonstrated that non-serotyped strains consisted of other serotypes which are not covered by the vaccine and in the light of this information, importance of the non-serotyped strains can be understood. Many of recently used pneumococcus vaccines has been known to be protective against the serotypes which have a high possibility to develop resistance; however, as stated in other studies, it can be discussed that protection by vaccination against serotypes which have high resistance possibility can increase the prevalence of other serotypes which the vaccine cannot be protective and this may provide the occurrence of an infection effect. Vaccine usage and its affect on serotype distribution and resistance rate of these serotypes should be monitored and more studies should be performed.
The results emphasize the global problem of resistant pneumococcus strains and the need for protection through multiple strategies. These strategies can be methods such as vaccination programs, antibiotics control programs and surveillance. 
